Our supply chain and production continue to operate according to plan and we do not foresee short-term issues due to COVID-19 that we cannot work around. Our experts constantly monitor and assess the global supply chain situation to ensure continued market supply. Where possible and needed, we activate alternative options to source from elsewhere in the world – either through third parties or through our own production.

There might be some delays due to limited transport capacities, but as we are producing pharmaceutical goods, we are getting special permits for maintaining production and shipment of goods, e.g. in Italy. From today’s perspective, we are confident we will not encounter any shortages.
 

NP-GB-102586 | December 2021